For cash-settled share-based payments, the entity recognises a liability measured at the fair value of the cash obligation at each reporting date, until the liability is settled. The expense for each period equals the movement in the liability — creating earnings volatility as the share price and other fair value inputs fluctuate (IFRS 2.30–33).
A cash-settled arrangement is one where the entity is obliged to pay cash (or other assets) to the counterparty in an amount based on the entity's share price or equity instruments. Common examples:
An entity with a constructive obligation to settle in cash — even if the formal terms say equity — must treat the arrangement as cash-settled (IFRS 2.3B).
The liability is:
Cumulative liability at each period-end:
The charge to P&L each period = movement in liability (i.e., the change in cumulative liability from one period-end to the next).
| Feature | Equity-settled | Cash-settled |
|---|---|---|
| Credit | Equity reserve | Liability |
| Remeasurement after grant date | Never | Every reporting date |
| P&L volatility from share price | No | Yes — directly |
| Vesting conditions | Revise expected vest number | Revise both: expected vest number AND fair value |
| Tax deduction timing | On exercise/vest | Often when cash is paid |
Setup: On 1 January 20X1, a company grants 2,000 SARs to an employee. The SARs vest after three years if the employee remains employed. On vesting, the employee will receive cash equal to the share price on the exercise date minus the base price of €20. There are no expected forfeitures.
Fair value of each SAR (option-pricing model, treated as a cash option):
| Date | Share price | SAR fair value | Vesting fraction | Liability |
|---|---|---|---|---|
| 31 Dec 20X1 | €24 | €6.80 | 1/3 | 2,000 × €6.80 × 1/3 = €4,533 |
| 31 Dec 20X2 | €27 | €9.10 | 2/3 | 2,000 × €9.10 × 2/3 = €12,133 |
| 31 Dec 20X3 | €30 | €11.00 | 3/3 | 2,000 × €11.00 × 1 = €22,000 |
| Account | Dr (€) | Cr (€) |
|---|---|---|
| Share-based payment expense | 4,533 | |
| SAR liability | 4,533 |
| Account | Dr (€) | Cr (€) |
|---|---|---|
| Share-based payment expense | 7,600 | |
| SAR liability | 7,600 |
| Account | Dr (€) | Cr (€) |
|---|---|---|
| Share-based payment expense | 9,867 | |
| SAR liability | 9,867 |
Cash payout: 2,000 × (€30 − €20) = €20,000.
| Account | Dr (€) | Cr (€) |
|---|---|---|
| SAR liability | 22,000 | |
| Cash | 20,000 | |
| Gain on settlement (P&L) | 2,000 |
The €2,000 gain arises because the liability was measured at the full option value (€11.00 per SAR) but the employee only receives intrinsic value (€10.00) — the time value is captured in the liability but not realised on exercise.
One of the most counter-intuitive aspects of cash-settled accounting: if the share price falls between reporting dates, the liability decreases — producing a credit (income) in profit or loss. This is correct under IFRS 2 and exactly mirrors economic reality — the entity's cash obligation has reduced.
Example: if the share price falls to €22 at the end of year 2 (instead of €27), the SAR fair value might be €4.20 and the liability would be 2,000 × €4.20 × 2/3 = €5,600. Compared to the year-1 liability of €4,533, the year-2 charge is only €1,067 — a much smaller P&L hit.